Search clinical trials for: hypofractionated 12x3 Gy integrated boost 12x4 Gy

Total 19 results

University of Erlangen-Nürnberg Medical School

Unknown

Efficacy of Dose Intensified Radiotherapy of Spinal Metastases by Hypofractionated Radiation and IGRT hfSRT Mediated Boost (SPIN-MET)

Spinal Metastases

Germany
Regina Elena Cancer Institute

Recruiting

External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients (ESIBIRE)

Breast Cancer | Breast Neoplasms

Italy
University Hospital, Ghent

Completed

Comparison of Acute Toxicity and Cost Between Whole Breast Irradiation With Sequential Boost and Simultaneous Integrated Boost After Breast Conserving Surgery. (SeqB vs SIB)

Radiotherapy After Breast Conserving Surgery

Belgium
Asan Medical Center

Completed

Androgen Deprivation Therapy, External Beam Radiotherapy and Stereotactic Radiosurgery Boost for Prostate Cancer (ADEBAR)

Neoplasm, Prostate

Korea, Republic of
Maria Sklodowska-Curie National Research Institute...

Active, not recruiting

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) (LIPOMYX)

Myxoid Liposarcoma

Poland
Wuhan Union Hospital, China

Unknown

Whole Versus Partial Vertebral Body IMRT for Spinal Metastases

Pain
Cancer Institute and Hospital, Chinese Academy...

Recruiting

A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN) (BIRKIN)

Breast Neoplasms

China
Institute of Cancer Research, United Kingdom

Unknown

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

Prostate Cancer

United Kingdom
Barretos Cancer Hospital

Terminated

Hypofractionated Radiotherapy for Nonmelanoma Skin Cancer

Non-melanoma Skin Cancer

Brazil
Emory University

Completed

Hypofractionated Radiotherapy in Breast Cancer

Inflammation | Cancer, Breast

United States
Kuopio University Hospital

Unknown

LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer Patients (BRAVEROBO)

Prostate Cancer

Finland
Institut Claudius Regaud

Recruiting

A Study to Evaluate Pre- or Post-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa. (HYPOSARC)

Soft Tissue Sarcoma

France
Fudan University

Unknown

Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving Surgery (HF-WBI-SIB)

Breast Cancer

China
University of Sydney
National Health and Medical Research Council, Australia; European Organisation... and other collaborators

Active, not recruiting

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer (ENZARAD)

Prostatic Neoplasms

United States, Australia, United Kingdom, Spain, New Zealand, Ireland, Austria, Belgium, Slovenia
Proton Collaborative Group
University of Florida Health

Recruiting

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

Prostate Cancer

United States
Medical University Innsbruck

Recruiting

HA-WBRT vs SRS in Patients With Multiple Brain Metastases (HipSter)

Brain Metastases

Austria
European Organisation for Research and Treatment...
Fondazione Italiana Linfomi ONLUS; Lymphoma Study Association

Unknown

Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma (H10)

Lymphoma

Netherlands
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer

Pancreatic Carcinoma

China
Zhejiang Cancer Hospital

Recruiting

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Gastric Cancer | Colorectal Cancer | Pancreatic Adenocarcinoma | Biliary Tract Cancer | Gastroesophageal Junction Adenocarcinoma | Liver Cancer Stage IV

China

3

Subscribe